We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Risk Factors for Venous Thromboembolism

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00018772
Recruitment Status : Completed
First Posted : July 5, 2001
Last Update Posted : January 21, 2009
Information provided by:
VA Office of Research and Development

Brief Summary:
Deep venous thrombosis is the presence of blood clots, usually in the legs that lead to either local problems or breathing problems if the clot moves to the lungs. This study is designed to assess both clinical conditions as well as common genetic factors that lead to more risk of deep venous thrombosis. Clinical conditions of venous thrombosis include: stroke, malignancy, and situations such as surgery, pregnancy, trauma, or travel.

Condition or disease
Deep Venous Thrombosis Pulmonary Embolism

Study Type : Observational
Time Perspective: Prospective
Official Title: 2779 Epidemiology of Genetic and Acquired Risk Factors for Venous Thrombosis
Study Start Date : April 1999
Estimated Study Completion Date : April 2003

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Patients must be 18 years with the ability to understand and consent to questionnaire and blood draw, including understanding of genetic testing..

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00018772

United States, Colorado
Denver, Colorado, United States, 80220
Sponsors and Collaborators
VA Office of Research and Development
OverallOfficial: Richard Marlar, Ph.D.

ClinicalTrials.gov Identifier: NCT00018772     History of Changes
Other Study ID Numbers: HEMA-013-98F
First Posted: July 5, 2001    Key Record Dates
Last Update Posted: January 21, 2009
Last Verified: December 2004

Keywords provided by VA Office of Research and Development:
thrombosis genetic markers

Additional relevant MeSH terms:
Venous Thromboembolism
Pulmonary Embolism
Venous Thrombosis
Embolism and Thrombosis
Vascular Diseases
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases